08:56     TEDA BIOMEDICAL<08189> - Announcement & Resumption (1)              

                                                                              
    This announcement is for information purposes only                        
    and does not constitute an invitation or offer to                         
    acquire, purchase or subscribe for securities. The                        
    Stock Exchange of Hong Kong Limited takes no                              
    responsibility for the contents of this announcement,                     
    makes no representation as to its accuracy or                             
    completeness and expressly disclaims any liability                        
    whatsoever for any loss howsoever arising from or in                      
    reliance upon the whole or any part of the contents                       
    of this announcement.                                                     
                                                                              
    Tianjin TEDA Biomedical Engineering Company Limited                       
    (a joint stock company incorporated in the People's                       
    Republic of China with limited liability)                                 
    (Stock Code: 8189)                                                        
                                                                              
    PLACING OF NEW PLACING H SHARES                                           
                                                                              
    Placing Agent                                                             
                                                                              
    SUN HUNG KAI INTERNATIONAL LIMITED                                        
                                                                              
    On 17 May 2005, the Company entered into the Placing                      
    Agreement with SHK under which the Company appointed                      
    SHK as the placing agent to conditionally place, on                       
    a fully underwritten basis, 231,000,000 New Placing                       
    H Shares of RMB0.10 each in the Company, representing                     
    57.75% of the existing issued share capital of the                        
    Company and approximately 37.87% of the issued share                      
    capital as enlarged by the Placing, to independent                        
    third parties at HK$0.161 per New Placing H Share.                        
    As at the date of this announcement, SHK has obtained                     
    written confirmations from the placees who have                           
    agreed to take up all the New Placing H Shares and                        
    therefore, SHK does not intend to take up itself 30%                      
    or more of the New Placing H Shares to be underwritten.                   
    The Placing Price of HK$0.161 is within the range of                      
    HK$0.161 to HK$0.186 as agreed by the Company and the                     
    Placing Agent under the New Placing Mandate and                           
    approved by the Shareholders under the Further                            
    Specific Mandate at the Shareholders' Meetings held                       
    on 21 December 2004.                                                      
                                                                              
    The 231,000,000 New Placing H Shares comprise                             
    210,000,000 New H Shares and 21,000,000 Sale H Shares                     
    converted from 21,000,000 Domestic Shares held by                         
    TTII pursuant to the State-owned Shares Reduction                         
    Regulations. The 210,000,000 New H Shares represent                       
    approximately 34.43% of the enlarged issued share                         
    capital of 610,000,000 Shares upon completion of the                      
    Placing and accordingly is within the 35% issued share                    
    capital limit specified under the Further Specific                        
    Mandate granted to Directors at the EGM held on 21                        
    December 2004.                                                            
                                                                              
    The Placing will reduce the aggregate shareholdings                       
    of TTII, the controlling shareholder of the Company                       
    from about 63.75% of the existing issued share capital                    
    to about 38.36% of the Company's issued share capital                     
    as enlarged by the Placing (after reduction of the                        
    21,000,000 Domestic Shares held by TTII which have                        
    been converted to Sale H Shares).                                         
                                                                              
    The New H Shares will be allotted and issued pursuant                     
    to the Further Specific Mandate granted to the                            
    Directors at the Shareholders' Meetings held on 21                        
    December 2004.                                                            
                                                                              
    The Placing is subject to the fulfillment of the                          
    conditions set out under the paragraph headed                             
    "Completion of the Placing" below.                                        
                                                                              
    On the basis of 210,000,000 New H Shares to be placed